VANCOMYCIN VERSUS LINEZOLID FOR TREATMENT OF MRSA PULMONARY EXACERBATIONS IN HOSPITALIZED PEDIATRIC CYSTIC FIBROSIS PATIENTS

被引：0
|
作者：
Ward, A. [1 ]
Kurzen, E. [1 ]
Travers, C. D. [4 ]
Duval, M. A. [1 ]
Linnemann, R. [2 ,3 ]
机构：
[1] Scottish Rite, Childrens Healthcare Atlanta, Pharm, Atlanta, GA USA
[2] Childrens Healthcare, Pulm, Atlanta, GA USA
[3] Emory Univ, Sch Med, Pediat Pulmonol, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Pediat Biostat Core, Atlanta, GA 30322 USA
来源：
PEDIATRIC PULMONOLOGY | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
392
引用
收藏
页码：296 / 297
页数：2
相关论文
共 50 条
  • [1] Comparative Effectiveness of Vancomycin Versus Linezolid for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis
    Fusco, Nicholas M.
    Meaney, Calvin J.
    Frederick, Carla A.
    Prescott, William A., Jr.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (03) : 197 - 204
  • [2] EFFICACY OF VANCOMYCIN VERSUS LINEZOLID FOR THE TREATMENT OF PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS WITH METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS
    Wood, M.
    Tansmore, J.
    Yin, H.
    Novak, K. J.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 344 - 345
  • [3] Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis
    Branstetter, Joshua
    Searcy, Heather
    Benner, Kim
    Yarbrough, April
    Crowder, Carly
    Troxler, Brad
    PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3337 - 3342
  • [4] Population Pharmacokinetics of Vancomycin Used in the Treatment of Pediatric Cystic Fibrosis Pulmonary Exacerbations
    Stockmann, Chris
    Sherwin, Catherine M. T.
    Zobell, Jeffery T.
    Lubsch, Lisa
    Young, David C.
    Olson, Jared
    Noyes, Blakeslee E.
    Ampofo, Krow
    Spigarelli, Michael G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S132 - S132
  • [5] Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults
    Esquivel, Marc D.
    Monogue, Marguerite L.
    Smith, Greg S.
    Finklea, James D.
    Sanders, James M.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 28 : 67 - 70
  • [6] EFFICACY AND TOLERABILITY OF CEFTAROLINE COMPARED TO VANCOMYCIN FOR THE TREATMENT OF ACUTE PULMONARY EXACERBATIONS IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS
    Searcy, H.
    Branstetter, J.
    Yarbrough, A.
    Hoover, W.
    Troxler, R.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S374 - S375
  • [7] Treatment of pulmonary exacerbations in cystic fibrosis
    Bhatt, Jayesh M.
    EUROPEAN RESPIRATORY REVIEW, 2013, 22 (129): : 205 - 216
  • [8] Treatment of pulmonary exacerbations in cystic fibrosis
    Ng, Christabella
    Nadig, Tejaswi
    Smyth, Alan R.
    Flume, Patrick
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (06) : 679 - 684
  • [9] Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis
    Lubovich, Silvina
    Zaragoza, Silvina
    Rodriguez, Viviana
    Buendia, Jefferson
    Camargo Vargas, Bethy
    Alchundia Moreira, Jessica
    Galanternik, Laura
    Ratto, Patricia
    Teper, Alejandro
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (05): : E466 - E471
  • [10] Linezolid versus vancomycin for MRSA nosocomial pneumonia
    不详
    FUTURE MICROBIOLOGY, 2010, 5 (12) : 1763 - 1763
12345